Document is current

Article History

Accepted: 10 November 2024

First Online: 18 January 2025

Declarations

:

: A.D. Sherry reports honoraria from Sermo. C.D. Tzeng reports research grants from Sirtex and consulting fees from PanTher. C. Tang reports grants from the Cancer Prevention & Research Institute of Texas (CPRIT), Noxopharm, and the Department of Defense (DoD), receiving royalties from Wolters Kluwer and Osler Institute, and receiving and consulting fees and honoraria from Siemen Healthineer, Lantheus, Telix, Molli Surgical, and Boston Scientific. T. A. Aguilera reports grants from the National Institutes of Health, royalties from UC San Diego and Stanford, and stock from Avelas Biosciences. E.J. Koay reports grants from National Institutes of Health, Stand Up 2 Cancer, MD Anderson Cancer Center, Philips Healthcare, Elekta, and GE Healthcare; personal fees from RenovoRx and Taylor and Francis; and a consulting/advisory role with Augmenix. P. Das reports honoraria from Bayer and ASTRO. S. Pant reports consulting fees from Zymeworks, Ipsen, Novartis, Janssen, Boehringer Ingelheim, AskGene Pharma, BPGbio, Jazz Pharmaceuticals, AstraZeneca, US WorldMeds, Nihon Medi-Physics, Alligator Bioscience, and research funding from Mirati Therapeutics, Lilly, Xencor, Novartis, Rgenix, Bristol Myers Squibb, Astellas Pharma, Purple Biotech, 4D Pharma, Boehringer Ingelheim, NGM Biopharmaceuticals, Janssen, Arcus Biosciences, Elicio Therapeutics, Bionte, Ipsen, Zymeworks, Pfizer, ImmunoMET, Immuneering, and Amal Therapeutics.